Skip to Main Content

Paper Details

Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer's disease patients.
J Transl Med
1
2023
Alzheimer's, Alzheimer's disease, Glutaminase, SA-25547, bortezomib, co-expressed genes, crizotinib, glial cell culture, glutamate, glutaminase, human, human cell lines, human tissues, mitochondrial dysfunction, mitoxantrone, neurodegeneration, neurons, parbendazole, patients, target gene, withaferin-a
Author NameAffiliation
Cheng ZhangKTH-Royal Institute of Technology
Adil MardinogluKing's College London
Adil MardinogluKTH-Royal Institute of Technology
Adil MardinogluKing's College London
Adil MardinogluKTH-Royal Institute of Technology
  • 1 - 5

Datasets

Release 1.2